Contract manufacturing

We offer contract manufacturing capabilities leveraging the quality, reliability and flexibility of our manufacturing facilities. We operate 29 manufacturing plants across the US, Europe and the MENA region.

Leveraging our high-quality local manufacturing expertise.

For all business development enquiries contact:

US and Canada:



We offer a broad range of capabilities for oral, nasal and injectable products.


Dosage forms


Dosage forms

Prefilled syringe


IV bags




Large parenteral

Oral solutions

Small parenteral


Specialised products

Specialised products

Cytotoxic/high containment

High containment




Controlled substances

Controlled substances



World class contract manufacturing in Columbus, OH, US
You can call us on 614-308-3500


Advanced sterile injectable manufacturing operations in the US and Europe


Hikma Pharmaceuticals reaffirms commitment to expanding access to overdose-reversal medicine naloxone at White House mee...

Press Release, Corporate 06 June 2024

Hikma opens new UK office to support NHS supply, strengthening European presence

Press Release, Corporate 03 June 2024

Hikma enters the Spanish generic injectables market, strengthening its European presence

Press Release, Corporate 20 May 2024

Hikma launches Midazolam Injection, USP, in a prefilled syringe in the US

Press Release, Corporate 08 May 2024

Bringing Better Health Within Reach: Hikma’s journey to become the Partner of choice in MENA

Insight, Corporate 29 April 2024

Hikma has strong start to 2024, with continued momentum across all businesses. Full year guidance reiterated

Press Release, Financial Results 25 April 2024

Hikma appoints Dr. Hafrun Fridriksdottir as President of Generics business

Press Release, Corporate 15 April 2024

Hikma’s Executive Vice Chairman and President of MENA Joins Rakuten Medical’s Board of Directors

Press Release, Corporate 07 March 2024

Hikma delivers strong 2023 performance and a positive outlook for 2024

Press Release, Financial Results 22 February 2024

Hikma hosts White House Drug Policy Director Dr. Rahul Gupta at its Columbus, Ohio manufacturing facility

Press Release, Corporate 21 February 2024
Related content

Explore more